NCT05056168

Validation of a Dermatology-Specific Treatment Satisfaction Instrument

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 120 (estimated)
• Sponsor: University of Southern California · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to validate a dermatology-specific questionnaire that assesses patient satisfaction with their treatments across various inflammatory dermatology diseases.

Conditions

• Psoriasis

Interventions

Type	Name	Description
OTHER	Dermatology-Specific Treatment Satisfaction Instrument	Study subjects will also be administered a dermatology-specific treatment satisfaction questionnaire, as well as other questionnaires including the generic validated Treatment Satisfaction Questionnaire for Medication (TSQM-9) and the validated Dermatology Life Quality Index (DLQI). Study participants will also self-report their disease severity using PGA. Depending on patients' preferred method of interacting with the study team, the investigators will collect their responses to these questionnaires either in-person, over the phone, or electronically via secure research platforms.

Timeline

• Start date: 2021-11-13
• Primary completion: 2023-03-14
• Completion: 2023-12-01
• First posted: 2021-09-24
• Last updated: 2023-11-15

Locations

1 site across 1 country: United States